KDventures as an investment
KDventures is a listed investment company focused on innovative Nordic life science companies. Through active ownership, specialist expertise and a portfolio with clear value drivers, we give our shareholders exposure to long-term value creation in life science. KDventures is listed on the NASDAQ Stockholm Stock Exchange.
SEK 0.89
Net asset value per share, 30 June 2026
SEK 677m
Net asset value, 30 June 2026
10
Portfolio companies
22
Exits, licence agreements and listings
Information for investors
Here you will find key information about KDventures as an investment, our ownership structure and the company’s financial performance.
KDventures has a broad shareholder base with both institutional and private investors. Here you can read more about our largest shareholders and the company’s ownership structure.
Here you will find our financial reports, presentations and other information that provides an overall picture of KDventures’ development, portfolio and financial position.
As a shareholder in KDventures, you gain exposure through a listed share to a portfolio of both listed and unlisted life science companies.
Latest press releases
See all press releasesKDventures’ portfolio company Umecrine Cognition reports last patient out in Phase 1b/2a study evaluating golexanolone in primary biliary cholangitis
KDventures portföljbolag Umecrine Cognition erhåller två Notice of Allowance i USA för andra generationens GAMSA-substanser
KDventures’ portfolio company Umecrine Cognition receives two Notices of Allowance in the US for second-generation GAMSA compounds
Investor Relations
Here you will find contact details for investor relations as well as links to financial reports, press releases, share information and corporate governance in our investor portal.